Forest Hill Capital LLC Takes Position in HealthEquity, Inc. (NASDAQ:HQY)

Forest Hill Capital LLC purchased a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY) during the 4th quarter, Holdings Channel.com reports. The fund purchased 30,476 shares of the company’s stock, valued at approximately $2,021,000. HealthEquity accounts for about 1.1% of Forest Hill Capital LLC’s portfolio, making the stock its 29th biggest holding.

Several other institutional investors have also added to or reduced their stakes in HQY. Janney Montgomery Scott LLC bought a new stake in shares of HealthEquity during the 3rd quarter worth approximately $217,000. Vanguard Personalized Indexing Management LLC grew its holdings in shares of HealthEquity by 6.1% in the third quarter. Vanguard Personalized Indexing Management LLC now owns 8,267 shares of the company’s stock worth $604,000 after purchasing an additional 477 shares during the last quarter. Pathstone Family Office LLC bought a new position in shares of HealthEquity in the third quarter worth about $230,000. HighTower Advisors LLC increased its stake in HealthEquity by 0.4% in the 3rd quarter. HighTower Advisors LLC now owns 86,940 shares of the company’s stock worth $6,366,000 after buying an additional 340 shares during the period. Finally, Deutsche Bank AG lifted its holdings in HealthEquity by 8.1% during the 3rd quarter. Deutsche Bank AG now owns 88,349 shares of the company’s stock valued at $6,454,000 after buying an additional 6,584 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

Insider Activity at HealthEquity

In other HealthEquity news, CEO Jon Kessler sold 33,765 shares of the business’s stock in a transaction dated Friday, March 22nd. The shares were sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the sale, the chief executive officer now directly owns 126,635 shares in the company, valued at $10,106,739.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CEO Jon Kessler sold 33,765 shares of HealthEquity stock in a transaction on Friday, March 22nd. The stock was sold at an average price of $79.81, for a total value of $2,694,784.65. Following the completion of the transaction, the chief executive officer now directly owns 126,635 shares in the company, valued at $10,106,739.35. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Evelyn S. Dilsaver sold 32,500 shares of the company’s stock in a transaction dated Tuesday, March 26th. The stock was sold at an average price of $79.29, for a total value of $2,576,925.00. Following the sale, the director now owns 32,123 shares in the company, valued at approximately $2,547,032.67. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 68,745 shares of company stock worth $5,482,530. 2.20% of the stock is currently owned by company insiders.

HealthEquity Trading Up 0.2 %

Shares of NASDAQ:HQY traded up $0.14 during midday trading on Thursday, reaching $83.21. 589,303 shares of the company’s stock were exchanged, compared to its average volume of 611,420. The firm’s 50 day simple moving average is $80.11 and its two-hundred day simple moving average is $76.81. HealthEquity, Inc. has a fifty-two week low of $59.02 and a fifty-two week high of $87.72. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.39 and a quick ratio of 4.39. The stock has a market cap of $7.24 billion, a price-to-earnings ratio of 88.90, a P/E/G ratio of 1.47 and a beta of 0.55.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, March 19th. The company reported $0.50 EPS for the quarter, topping the consensus estimate of $0.42 by $0.08. The firm had revenue of $262.39 million for the quarter, compared to analyst estimates of $258.56 million. HealthEquity had a net margin of 7.71% and a return on equity of 7.77%. As a group, sell-side analysts forecast that HealthEquity, Inc. will post 2.11 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts recently issued reports on HQY shares. Royal Bank of Canada reissued an “outperform” rating and issued a $92.00 price objective on shares of HealthEquity in a research note on Tuesday, June 4th. JMP Securities increased their price target on HealthEquity from $101.00 to $105.00 and gave the stock a “market outperform” rating in a research report on Tuesday, June 4th. Wells Fargo & Company boosted their price objective on HealthEquity from $105.00 to $107.00 and gave the stock an “overweight” rating in a research note on Tuesday, June 4th. JPMorgan Chase & Co. lifted their price target on HealthEquity from $86.00 to $108.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 2nd. Finally, Raymond James increased their price objective on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Friday, June 7th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $101.42.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.